NLRP3 and atherosclerosis: Arglabin, a plant-derived compound, inhibited the activity of the NLRP3 inflammasome and significantly reduced the production of IL-1α, IL-1β, and IL-18, reducing the production of proinflammatory mediators to alleviate atherosclerosis [73].